UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Number of items: 95.


Ahlskog, JKJ; Schliemann, C; Marlind, J; Qureshi, U; Ammar, A; Pedley, RB; Neri, D; (2009) Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours. BRIT J CANCER , 101 (4) 645 - 657. 10.1038/sj.bjc.6605200.

Arkenau, HT; (2009) Gastric cancer in the era of molecularly targeted agents: current drug development strategies. J Cancer Res Clin Oncol , 135 (7) 855 - 866. 10.1007/s00432-009-0583-7.

Arkenau, HT; Barriuso, J; Olmos, D; Ang, JE; de Bono, J; Judson, I; Kaye, S; (2009) Prospective validation of a prognostic score to improve patient selection for oncology phase I trials. J Clin Oncol , 27 (16) 2692 - 2696. 10.1200/JCO.2008.19.5081.

Baou, M; Jewell, A; Muthurania, A; Wickremasinghe, RG; Yong, KL; Carr, R; ... Murphy, JJ; + view all (2009) Involvement of Tis11b, an AU-rich binding protein, in induction of apoptosis by rituximab in B cell chronic lymphocytic leukemia cells. LEUKEMIA , 23 (5) 986 - 989. 10.1038/leu.2008.340.

Bell, CG; Beck, S; (2009) Advances in the identification and analysis of allele-specific expression. Genome Med , 1 (5) 56 - ?. 10.1186/gm56.

Bellodi, C; Lidonnici, MR; Hamilton, A; Helgason, GV; Soliera, AR; Ronchetti, M; ... Calabretta, B; + view all (2009) Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. J CLIN INVEST , 119 (5) 1109 - 1123. 10.1172/JCI35660.

Brunelli, M; Manfrin, E; Martignoni, G; Miller, K; Remo, A; Reghellin, D; ... Bonetti, F; + view all (2009) Genotypic Intratumoral Heterogeneity in Breast Carcinoma With HER2/neu Amplification. AM J CLIN PATHOL , 131 (5) 678 - 682. 10.1309/AJCP09VUTZWZXBMJ.

Camp, PG; Coxson, HO; Levy, RD; Pillai, SG; Anderson, W; Vestbo, J; ... Paré, PD; + view all (2009) Sex differences in emphysema and airway disease in smokers. Chest , 136 (6) 1480 - 1488. 10.1378/chest.09-0676.

Chiou, A; Hägglöf, P; Orte, A; Chen, AY; Dunne, PD; Belorgey, D; ... Klenerman, D; + view all (2009) Probing neuroserpin polymerization and interaction with amyloid-beta peptides using single molecule fluorescence. Biophys J , 97 (8) 2306 - 2315. 10.1016/j.bpj.2009.07.057.

Davies, MJ; Miranda, E; Roussel, BD; Kaufman, RJ; Marciniak, SJ; Lomas, DA; (2009) Neuroserpin polymers activate NF-kappaB by a calcium signaling pathway that is independent of the unfolded protein response. J Biol Chem , 284 (27) 18202 - 18209. 10.1074/jbc.M109.010744.

DeMeo, DL; Mariani, T; Bhattacharya, S; Srisuma, S; Lange, C; Litonjua, A; ... Silverman, EK; + view all (2009) Integration of genomic and genetic approaches implicates IREB2 as a COPD susceptibility gene. Am J Hum Genet , 85 (4) 493 - 502. 10.1016/j.ajhg.2009.09.004.

Ekeowa, UI; Gooptu, B; Belorgey, D; Hägglöf, P; Karlsson-Li, S; Miranda, E; ... Lomas, DA; + view all (2009) alpha1-Antitrypsin deficiency, chronic obstructive pulmonary disease and the serpinopathies. Clin Sci (Lond) , 116 (12) 837 - 850. 10.1042/CS20080484.

Emuss, V; Lagos, D; Pizzey, A; Gratrix, F; Henderson, SR; Boshoff, C; (2009) KSHV Manipulates Notch Signaling by DLL4 and JAG1 to Alter Cell Cycle Genes in Lymphatic Endothelia. PLoS Pathogens , 5 (10) , Article e1000616. 10.1371/journal.ppat.1000616. Green and gold open access

Enver, T; Pera, M; Peterson, C; Andrews, PW; (2009) Stem Cell States, Fates, and the Rules of Attraction. CELL STEM CELL , 4 (5) 387 - 397. 10.1016/j.stem.2009.04.011.

Fielding, AK; Rowe, JM; Richards, SM; Buck, G; Moorman, AV; Durrant, IJ; ... Goldstone, AH; + view all (2009) Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993. BLOOD , 113 (19) 4489 - 4496. 10.1182/blood-2009-01-199380.

Ford, AM; Palmi, C; Bueno, C; Hong, D; Cardus, P; Knight, D; ... Greaves, M; + view all (2009) The TEL-AML1 leukemia fusion gene dysregulates the TGF-beta pathway in early B lineage progenitor cells. J CLIN INVEST , 119 (4) 826 - 836. 10.1172/JCI36428.

Gandhi, S; Wood-Kaczmar, A; Yao, Z; Plun-Favreau, H; Deas, E; Klupsch, K; ... Abramov, AY; + view all (2009) PINK1-Associated Parkinson's Disease Is Caused by Neuronal Vulnerability to Calcium-induced Cell Death. MOL CELL , 33 (5) 627 - 638. 10.1016/j.molcel.2009.02.013. Gold open access

Garofalo, M; Di Leva, G; Romano, G; Nuovo, G; Suh, SS; Ngankeu, A; ... Croce, CM; + view all (2009) miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation. CANCER CELL , 16 (6) 498 - 509. 10.1016/j.ccr.2009.10.014.

Gooptu, B; Ekeowa, UI; Lomas, DA; (2009) Mechanisms of emphysema in alpha1-antitrypsin deficiency: molecular and cellular insights. Eur Respir J , 34 (2) 475 - 488. 10.1183/09031936.00096508.

Gooptu, B; Lomas, DA; (2009) Conformational pathology of the serpins: themes, variations, and therapeutic strategies. Annu Rev Biochem , 78 147 - 176. 10.1146/annurev.biochem.78.082107.133320.

Gooptu, B; Miranda, E; Nobeli, I; Mallya, M; Purkiss, A; Brown, SC; ... Barrett, TE; + view all (2009) Crystallographic and cellular characterisation of two mechanisms stabilising the native fold of alpha1-antitrypsin: implications for disease and drug design. J Mol Biol , 387 (4) 857 - 868. 10.1016/j.jmb.2009.01.069.

Gordon, WR; Roy, M; Vardar-Ulu, D; Garfinkel, M; Mansour, MR; Aster, JC; Blacklow, SC; (2009) Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALL. Blood , 113 (18) 4381 - 4390. 10.1182/blood-2008-08-174748.

Graf, T; Enver, T; (2009) Forcing cells to change lineages. NATURE , 462 (7273) 587 - 594. 10.1038/nature08533.

Grimwade, D; Jovanovic, JV; Hills, RK; Nugent, EA; Patel, Y; Flora, R; ... Burnett, AK; + view all (2009) Prospective Minimal Residual Disease Monitoring to Predict Relapse of Acute Promyelocytic Leukemia and to Direct Pre-Emptive Arsenic Trioxide Therapy. J CLIN ONCOL , 27 (22) 3650 - 3658. 10.1200/JCO.2008.20.1533.

Grun, B; Benjamin, E; Sinclair, J; Timms, JF; Jacobs, IJ; Gayther, SA; Dafou, D; (2009) Three-dimensional in vitro cell biology models of ovarian and endometrial cancer. CELL PROLIFERAT , 42 (2) 219 - 228. 10.1111/j.1365-2184.2008.00579.x.

Hadjur, S; Williams, LM; Ryan, NK; Cobb, BS; Sexton, T; Fraser, P; ... Merkenschlager, M; + view all (2009) Cohesins form chromosomal cis-interactions at the developmentally regulated IFNG locus. NATURE , 460 (7253) 410 - U130. 10.1038/nature08079.

Hersh, CP; Hansel, NN; Barnes, KC; Lomas, DA; Pillai, SG; Coxson, HO; ... ICGN Investigators,; + view all (2009) Transforming growth factor-beta receptor-3 is associated with pulmonary emphysema. Am J Respir Cell Mol Biol , 41 (3) 324 - 331. 10.1165/rcmb.2008-0427OC.

Hochhauser, D; Meyer, T; Spanswick, VJ; Wu, J; Clingen, PH; Loadman, P; ... Jodrell, D; + view all (2009) Phase I Study of Sequence-Selective Minor Groove DNA Binding Agent SJG-136 in Patients with Advanced Solid Tumors. CLIN CANCER RES , 15 (6) 2140 - 2147. 10.1158/1078-0432.CCR-08-1315.

Howie, AJ; Brewer, DB; (2009) Optical properties of amyloid stained by Congo red: history and mechanisms. Micron , 40 (3) 285 - 301. 10.1016/j.micron.2008.10.002.

Joly, P; Jennings, BH; Jayasinghe, SN; (2009) Development and fertility studies on post-bio-electrosprayed Drosophila melanogaster embryos. BIOMICROFLUIDICS , 3 (4) , Article 044107. 10.1063/1.3267044.

Kim, BS; Miyagawa, F; Cho, Y-H; Bennett, CL; Clausen, BE; Katz, SI; (2009) Keratinocytes Function as Accessory Cells for Presentation of Endogenous Antigen Expressed in the Epidermis. JOURNAL OF INVESTIGATIVE DERMATOLOGY , 129 (12) 2805 - 2817. 10.1038/jid.2009.176.

Kirk, P; Roughton, M; Porter, JB; Walker, JM; Tanner, MA; Patel, J; ... Pennell, DJ; + view all (2009) Cardiac T2*Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia Major. CIRCULATION , 120 (20) 1961 - U23. 10.1161/CIRCULATIONAHA.109.874487.

Kishnani, PS; DiRocco, M; Kaplan, P; Mehta, A; Pastores, GM; Smith, SE; ... Lemay, RMWNJ; + view all (2009) A randomized trial comparing the efficacy and safety of imiglucerase (Cerezyme) infusions every 4 weeks versus every 2 weeks in the maintenance therapy of adult patients with Gaucher disease type 1. Molecular genetics and metabolism 10.1016/j.ymgme.2008.12.015.

Kocjan, G; Chandra, A; Cross, P; Denton, K; Giles, T; Herbert, A; ... Wilson, P; + view all (2009) BSCC Code of Practice - fine needle aspiration cytology. CYTOPATHOLOGY , 20 (5) 283 - 296. 10.1111/j.1365-2303.2009.00709.x.

Kocjan, G; Ramsay, A; Beale, T; O'Flynn, P; (2009) Head and neck cancer in the UK: what is expected of cytopathology? CYTOPATHOLOGY , 20 (2) 69 - 77. 10.1111/j.1365-2303.2009.00647.x.

Kong, X; Coxson, H; Lomas, DA; Silverman, EK; Pillai, SG; Investigators, ECLIPSE; (2009) Genome-Wide Association Study (GWA) of High Resolution CT Defined Emphysema Phenotypes in Two Independent COPD Populations. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE , 179

Kroeger, H; Miranda, E; MacLeod, I; Pérez, J; Crowther, DC; Marciniak, SJ; Lomas, DA; (2009) Endoplasmic reticulum-associated degradation (ERAD) and autophagy cooperate to degrade polymerogenic mutant serpins. J Biol Chem , 284 (34) 22793 - 22802. 10.1074/jbc.M109.027102.

Kummar, S; Doroshow, JH; Tomaszewski, JE; Calvert, AH; Lobbezoo, M; Giaccone, G; Task Force MDICT,; (2009) Phase 0 clinical trials: Recommendations from the task force on methodology for the development of innovative cancer therapies. EUR J CANCER , 45 (5) 741 - 746. 10.1016/j.ejca.2008.10.024.

Lawrie, AS; Albanyan, A; Cardigan, RA; Mackie, IJ; Harrison, P; (2009) Microparticle sizing by dynamic light scattering in fresh-frozen plasma. VOX SANG , 96 (3) 206 - 212. 10.1111/j.1423-0410.2008.01151.x.

Lee, SM; Woll, PJ; Rudd, R; Ferry, D; O'Brien, M; Middleton, G; ... Hackshaw, A; + view all (2009) Anti-angiogenic therapy using thalidomide combined with chemotherapy in small cell lung cancer: a randomized, double-blind, placebo-controlled trial. J Natl Cancer Inst , 101 (15) 1049 - 1057. 10.1093/jnci/djp200. Green open access

Leedham, SJ; Graham, TA; Oukrif, D; McDonald, SAC; Rodriguez-Justo, M; Harrison, RF; ... Wright, NA; + view all (2009) Clonality, Founder Mutations, and Field Cancerization in Human Ulcerative Colitis-Associated Neoplasia. GASTROENTEROLOGY , 136 (2) 542 - 550. 10.1053/j.gastro.2008.10.086.

Li, W; Ferguson, BJ; Khaled, WT; Tevendale, M; Stingl, J; Poli, V; ... Watson, CJ; + view all (2009) PML depletion disrupts normal mammary gland development and skews the composition of the mammary luminal cell progenitor pool. P NATL ACAD SCI USA , 106 (12) 4725 - 4730. 10.1073/pnas.0807640106.

Lomas, DA; Silverman, EK; Edwards, LD; Locantore, NW; Miller, BE; Horstman, DH; ... Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints study investigators,; + view all (2009) Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD. Eur Respir J , 34 (1) 95 - 102. 10.1183/09031936.00156508.

Lomas, DA; Silverman, EK; Edwards, LD; Miller, BE; Tal-Singer, R; Investigators, ECLIPSE; (2009) Serum Surfactant Protein D Is Associated with Exacerbations of COPD. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE , 179

Lopez, MN; Pereda, C; Segal, G; Munoz, L; Aguilera, R; Gonzalez, FE; ... Salazar-Onfray, F; + view all (2009) Prolonged Survival of Dendritic Cell-Vaccinated Melanoma Patients Correlates With Tumor-Specific Delayed Type IV Hypersensitivity Response and Reduction of Tumor Growth Factor beta-Expressing T Cells. J CLIN ONCOL , 27 (6) 945 - 952. 10.1200/JCO.2008.18.0794.

Lucas, A; Liu, L; Dai, E; Bot, I; Viswanathan, K; Munuswamy-Ramunujam, G; ... McFadden, G; + view all (2009) The serpin saga; development of a new class of virus derived anti-inflammatory protein immunotherapeutics. Adv Exp Med Biol , 666 132 - 156.

Mansour, MR; (2009) Oncogenic Kras and Notch-1 cooperate in T-cell acute lymphoblastic leukemia/lymphoma. Expert Rev Hematol , 2 (2) 133 - 136. 10.1586/ehm.09.3.

Marciniak, SJ; Lomas, DA; (2009) What can naturally occurring mutations tell us about the pathogenesis of COPD? Thorax , 64 (4) 359 - 364. 10.1136/thx.2008.099408.

Marks, DI; Paietta, EM; Moorman, AV; Richards, SM; Buck, G; DeWald, G; ... Lazarus, HM; + view all (2009) T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993). BLOOD , 114 (25) 5136 - 5145. 10.1182/blood-2009-08-231217.

Nerelius, C; Sandegren, A; Sargsyan, H; Raunak, R; Leijonmarck, H; Chatterjee, U; ... Johansson, J; + view all (2009) Alpha-helix targeting reduces amyloid-beta peptide toxicity. Proc Natl Acad Sci U S A , 106 (23) 9191 - 9196. 10.1073/pnas.0810364106.

Novakovic, B; Sibson, M; Ng, HK; Manuelpillai, U; Rakyan, V; Down, T; ... Saffery, R; + view all (2009) Placenta-specific methylation of the vitamin d 24-hydroxylase gene implications for feedback autoregulation of active vitamin d levels at the fetomaternal interface. The journal of biological chemistry , 284 (22) 14838 - 14848. 10.1074/jbc.M809542200. Green and gold open access

O' Reilly, LA; Tai, L; Lee, L; Kruse, EA; Grabow, S; Fairlie, WD; ... Strasser, A; + view all (2009) Membrane-bound Fas ligand only is essential for Fas-induced apoptosis. Nature , 461 (7264) 659 - 663. 10.1038/nature08402.

Olmos, D; Arkenau, HT; Ang, JE; Ledaki, I; Attard, G; Carden, CP; ... de Bono, JS; + view all (2009) Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience. Ann Oncol , 20 (1) 27 - 33. 10.1093/annonc/mdn544.

Ooi, SKT; O'Donnell, AH; Bestor, TH; (2009) Mammalian cytosine methylation at a glance. J CELL SCI , 122 (16) 2787 - 2791. 10.1242/jcs.015123.

Peggs, KS; Quezada, SA; Chambers, CA; Korman, AJ; Allison, JP; (2009) Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies. J EXP MED , 206 (8) 1717 - 1725. 10.1084/jem.20082492.

Peggs, KS; Verfuerth, S; Pizzey, A; Chow, SLC; Thomson, K; Mackinnon, S; (2009) Cytomegalovirus-Specific T Cell Immunotherapy Promotes Restoration of Durable Functional Antiviral Immunity following Allogeneic Stem Cell Transplantation. CLIN INFECT DIS , 49 (12) 1851 - 1860. 10.1086/648422.

Pillai, SG; Ge, D; Zhu, G; Kong, X; Shianna, KV; Need, AC; ... ICGN Investigators,; + view all (2009) A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet , 5 (3) e1000421 . 10.1371/journal.pgen.1000421. Green and gold open access

Pillai, SG; Kong, X; Coxson, H; Lomas, DA; Silverman, EK; Investigators, ECLIPSE; (2009) Association Analysis of Two Novel, Replicated COPD Susceptibility Genes in the ECLIPSE Cohort. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE , 179

Pollard, SM; Yoshikawa, K; Clarke, ID; Danovi, D; Stricker, S; Russell, R; ... Dirks, P; + view all (2009) Glioma Stem Cell Lines Expanded in Adherent Culture Have Tumor-Specific Phenotypes and Are Suitable for Chemical and Genetic Screens. CELL STEM CELL , 4 (6) 568 - 580. 10.1016/j.stem.2009.03.014.

Regad, T; Bellodi, C; Nicotera, P; Salomoni, P; (2009) The tumor suppressor Pml regulates cell fate in the developing neocortex. NAT NEUROSCI , 12 (2) 132 - 140. 10.1038/nn.2251.

Rival, T; Page, RM; Chandraratna, DS; Sendall, TJ; Ryder, E; Liu, B; ... Lomas, DA; + view all (2009) Fenton chemistry and oxidative stress mediate the toxicity of the beta-amyloid peptide in a Drosophila model of Alzheimer's disease. Eur J Neurosci , 29 (7) 1335 - 1347. 10.1111/j.1460-9568.2009.06701.x.

Salomoni, P; Michod, D; (2009) End of the Daxx diatribe? CELL CYCLE , 8 (10) 1467 - 1468.

Seymour, LW; Ferry, DR; Kerr, DJ; Rea, D; Whitlock, M; Poyner, R; ... Cassidy, J; + view all (2009) Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer. INT J ONCOL , 34 (6) 1629 - 1636. 10.3892/ijo_00000293.

Shah, SP; Morin, RD; Khattra, J; Prentice, L; Pugh, T; Burleigh, A; ... Aparicio, S; + view all (2009) Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. NATURE , 461 (7265) 809 - U67. 10.1038/nature08489.

Spencer, J; Rathnam, RP; Motukuri, M; Kotha, AK; Richardson, SCW; Hazrati, A; ... Hursthouse, MB; + view all (2009) Synthesis of a 1,4-benzodiazepine containing palladacycle with in vitro anticancer and cathepsin B activity. DALTON T (22) 4299 - 4303. 10.1039/b819061e.

Steele, AJ; Prentice, AG; Hoffbrand, AV; Yogashangary, BC; Hart, SM; Lowdell, MW; ... Wickremasinghe, RG; + view all (2009) 2-phenylacetylenesulfonamide (PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells. BLOOD , 114 (6) 1217 - 1225. 10.1182/blood-2008-11-190587.

Steele, AJ; Prentice, AG; Hoffbrand, AV; Yogashangary, BC; Hart, SM; Lowdell, MW; ... Wickremasinghe, RG; + view all (2009) 2-Phenylacetylenesulfonamide (PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells. Blood , 114 (6) 1217 - 1225. 10.1182/blood-2008-11-190587.

Steele, AJ; Prentice, AG; Hoffbrand, AV; Yogashangary, BC; Hart, SM; Lowdell, MW; ... Wickremasinghe, RG; + view all (2009) 2-Phenylacetylenesulfonamide (PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells. Blood , 114 (6) 1217 - 1225. 10.1182/blood-2008-11-190587.

Taher, A; Cappellini, MD; Vichinsky, E; Galanello, R; Piga, A; Lawniczek, T; ... Porter, JB; + view all (2009) Efficacy and safety of deferasirox doses of > 30 mg/kg per d in patients with transfusion-dependent anaemia and iron overload. BRIT J HAEMATOL , 147 (5) 752 - 759. 10.1111/j.1365-2141.2009.07908.x.

Takehara, S; Onda, M; Zhang, J; Nishiyama, M; Yang, X; Mikami, B; Lomas, DA; (2009) The 2.1-A crystal structure of native neuroserpin reveals unique structural elements that contribute to conformational instability. J Mol Biol , 388 (1) 11 - 20. 10.1016/j.jmb.2009.03.007.

Tan, MH; Smith, AJ; Pawlyk, B; Xu, XY; Liu, XQ; Bainbridge, JB; ... Ali, RR; + view all (2009) Gene therapy for retinitis pigmentosa and Leber congenital amaurosis caused by defects in AIPL1: effective rescue of mouse models of partial and complete Aipl1 deficiency using AAV2/2 and AAV2/8 vectors. Human Molecular Genetics , 18 (12) 2099 - 2114. 10.1093/hmg/ddp133. Green and gold open access

Teschendorff, AE; Caldas, C; (2009) The breast cancer somatic 'muta-ome': tackling the complexity. BREAST CANCER RES , 11 (2) , Article 301. 10.1186/bcr2236.

Teschendorff, AE; Menon, U; Gentry-Maharaj, A; Ramus, SJ; Gayther, SA; Apostolidou, S; ... Widschwendter, M; + view all (2009) An Epigenetic Signature in Peripheral Blood Predicts Active Ovarian Cancer. PLOS ONE , 4 (12) , Article e8274. 10.1371/journal.pone.0008274. Green and gold open access

Tipping, AJ; Pina, C; Castor, A; Hong, DL; Rodrigues, NP; Lazzari, L; ... Enver, T; + view all (2009) High GATA-2 expression inhibits human hematopoietic stem and progenitor cell function by effects on cell cycle. BLOOD , 113 (12) 2661 - 2672. 10.1182/blood-2008-06-161117.

Tulpule, S; Shaw, BE; Makoni, P; Little, AM; Madrigal, JA; Goldman, JM; (2009) Severe allergic reaction with anaphylaxis to G-CSF (lenograstim) in a healthy donor. BONE MARROW TRANSPL , 44 (2) 129 - 130. 10.1038/bmt.2008.438.

Udler, MS; Azzato, EM; Healey, CS; Ahmed, S; Pooley, KA; Greenberg, D; ... Pharoah, PD; + view all (2009) Common germline polymorphisms in COMT, CYP19A1, ESR1, PGR, SULT1E1 and STS and survival after a diagnosis of breast cancer. INT J CANCER , 125 (11) 2687 - 2696. 10.1002/ijc.24678.

Valle, JW; Wasan, H; Johnson, P; Jones, E; Dixon, L; Swindell, R; ... Bridgewater, J; + view all (2009) Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study. BRIT J CANCER , 101 (4) 621 - 627. 10.1038/sj.bjc.6605211.

Velica, P; Davies, NJ; Rocha, PP; Schrewe, H; Ride, JP; Bunce, CM; (2009) Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers. MOL CANCER , 8 , Article 121. 10.1186/1476-4598-8-121. Gold open access

Vergote, I; Calvert, H; Kania, M; Kaiser, C; Zimmermann, AH; Sehouli, J; (2009) A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancer. EUR J CANCER , 45 (8) 1415 - 1423. 10.1016/j.ejca.2008.12.013.

Visone, R; Rassenti, LZ; Veronese, A; Taccioli, C; Costinean, S; Aguda, BD; ... Croce, CM; + view all (2009) Karyotype-specific microRNA signature in chronic lymphocytic leukemia. BLOOD , 114 (18) 3872 - 3879. 10.1182/blood-2009-06-229211.

Wang, D-P; Wan, H-L; Zhang, S; Yu, J; (2009) γ-MYN: a new algorithm for estimating Ka and Ks with consideration of variable substitution rates. Biology Direct , 4 (1) 20 - 20. 10.1186/1745-6150-4-20. Gold open access

Werbowetski-Ogilvie, TE; Bossé, M; Stewart, M; Schnerch, A; Ramos-Mejia, V; Rouleau, A; ... Bhatia, M; + view all (2009) Characterization of human embryonic stem cells with features of neoplastic progression. Nat Biotechnol , 27 (1) 91 - 97. 10.1038/nbt.1516.

Wiegant, FA; Surinova, S; Ytsma, E; Langelaar-Makkinje, M; Wikman, G; Post, JA; (2009) Plant adaptogens increase lifespan and stress resistance in C. elegans. Biogerontology , 10 (1) 27 - 42. 10.1007/s10522-008-9151-9.

Wu, P; Davies, FE; Boyd, K; Thomas, K; Dines, S; Saso, RM; ... Morgan, GJ; + view all (2009) The impact of extramedullary disease at presentation on the outcome of myeloma. LEUKEMIA LYMPHOMA , 50 (2) 230 - 235. 10.1080/10428190802657751.

Zhang, EZ; Laufer, JG; Pedley, RB; Beard, PC; (2009) In vivo high-resolution 3D photoacoustic imaging of superficial vascular anatomy. PHYS MED BIOL , 54 (4) 1035 - 1046. 10.1088/0031-9155/54/4/014.

Zhu, G; Agusti, A; Gulsvik, A; Bakke, P; Coxson, H; Lomas, DA; ... ICGN investigators,; + view all (2009) CTLA4 gene polymorphisms are associated with chronic bronchitis. Eur Respir J , 34 (3) 598 - 604. 10.1183/09031936.00141808.

Zhu, G; ICGN Investigators,; Gulsvik, A; Bakke, P; Ghatta, S; Anderson, W; ... Pillai, SG; + view all (2009) Association of TRPV4 gene polymorphisms with chronic obstructive pulmonary disease. Hum Mol Genet , 18 (11) 2053 - 2062. 10.1093/hmg/ddp111.

Book chapter

Rees, J; Short, S; Townsley, E; Zadeh, G; Brandner, S; Howard, R; ... Thomas, D; + view all (2009) Neuro-Oncology. In: UNSPECIFIED (771 - 822).

Proceedings paper

Banerjee, L; Mansour, M; Khwaja, A; (2009) Combined blockade of PI3-kinase and mTOR synergizes with gamma-secretase inhibitors to induce a high level of cell death in T-cell acute lymphoblastic leukaemia cells with activated Notch signalling. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 9 - 10). WILEY-BLACKWELL PUBLISHING, INC

Bartlett, JMS; Campbell, FM; Ibrahim, M; Thomas, J; Wenyck, I; Ellis, IO; ... Miller, K; + view all (2009) A UK NEQAS ring study evaluating observer variation in the diagnosis of HER2 amplification using the Kreatech (TM) HER2 FISH probe. In: CANCER RESEARCH. (pp. 206S - 206S). AMER ASSOC CANCER RESEARCH

Knight, A; Mackinnon, S; Lowdell, MW; (2009) CMV-Reactive Gamma/Delta T Cells Expanded From CMV Seronegative Normal Healthy Individuals Lyse CMV-Infected Targets - Potential Adoptive Immunotherapy for Recipients of Stem Cell Transplants From CMV Seronegative Donors. In: BLOOD. (pp. 880 - 880). AMER SOC HEMATOLOGY

Peggs, KS; Thomson, K; Samuel, E; Dyer, G; Armoogum, J; Pang, K; ... Lowdell, MW; + view all (2009) Adoptive Transfer of CMV-Specific Donor T Cells Following Allogeneic Transplantation Leads to Rapid and Safe Systemic Reconstitution. In: BLOOD. (pp. 24 - 24). AMER SOC HEMATOLOGY

Postel-Vinay, S; Arkenau, HT; Olmos, D; Ang, J; Barriuso, J; Ashley, S; ... Kaye, S; + view all (2009) Clinical benefit in Phase-I trials of novel molecularly targeted agents: does dose matter? In: Br J Cancer. (pp. 1373 - 1378).

Reyal, F; Vliet, MH; Horlings, HH; Armstrong, N; de Visser, KE; Kok, M; ... Wessels, LF; + view all (2009) A comprehensive analysis of nine prognostic signatures reveals the high classification instability in breast cancer. In: CANCER RESEARCH. (pp. 164S - 164S). AMER ASSOC CANCER RESEARCH

Vontell, R; McGuinness, L; Goldring, K; David, D; John, S; (2009) Antigen retrieval improves the immunoreactivity of cells and receptor sites of the basal ganglia on rat and human brains. In: MOVEMENT DISORDERS. (pp. S218 - S218). WILEY-LISS

This list was generated on Fri Nov 21 13:59:29 2014 GMT.